trending Market Intelligence /marketintelligence/en/news-insights/trending/wQAPf1hn0MxAr87ZVxC-vA2 content esgSubNav
In This List

AbbVie secures additional $1B in credit facility

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


AbbVie secures additional $1B in credit facility

North Chicago, Ill.-based biotechnology company AbbVie Inc. negotiated a $1 billion increase in its credit facility provided by lenders represented by JPMorgan Chase Bank NA.

The company can now borrow up to $4 billion under the facility which is unsecured, up from $3 billion previously. The credit facility also now expires on Aug. 27, 2024, as opposed to Aug. 31, 2023.

Earlier this year, AbbVie announced it would be acquiring Botox-maker Allergan PLC for $63 billion, and that it had secured funding from multiple sources to fund the deal.